We are pleased to be back in Bristol on 21 November for a collaborative BioTuesday event alongside Future Space​, where we'll be spotlighting the latest innovation in TechBio.

TechBio is an emerging and exciting area of data-driven research where biotech companies are using cutting-edge techniques that combine hardware and software support to transform drug discovery and patient care.  

During the evening our keynote speaker will share a broad introduction to the TechBio space, including the impact this unique research area is likely to have on life sciences, followed by a regional funding update, and a showcase of five early-stage TechBio focused companies. 

Attendance at this event is complimentary for OBN members, academics, students and research scientists, with a nominal fee applicable for non-OBN members. 

Programme:

18.00 – 18.30   Guest arrivals and networking

18.30 – 19.00  Welcome & Keynote Presentations, sharing a broad introduction to TechBio and a regional funding update

• Richard Luxton, Co-Founder, Institute of Bio-Sensing Technology
• Shawn Manning, NED and Adviser; Life Science and Associated Industries, Akesios Associates​

19.00 - 20.00   R&D Showcase Presentations, featuring 5 exciting TechBio focused R&D companies

• Paul Ko Ferrigno, CEO, Eclateral
• Zeke Steer, Founder & CEO, Milbotix
• Neciah Dorh, CEO, Fluoretiq
• David Browning, Strategic Advisor,  EarSwitch
• Gunjita Singh, Senior Scientist,  Antiverse​

 20.00 - 20.30  Audience & Presenter Q&A

20.30 – 21.30   Networking

About Future Space

Based on the UWE Bristol campus, Future Space offers a range of office space, shared and dedicated laboratories, workshops and coworking facilities designed specifically for high-tech, science based entrepreneurs and innovators.